Literature DB >> 846182

[Plasma concentrations after injection or infusion of phenytoin (author's transl)].

D Schmidt, A Vogel.   

Abstract

Intravenous injection of 3 mg/kg phenytoin produced plasma concentrations of 4.2 mug/ml in five volunteers, which were below the concentration of 10-20 mjg/ml necessary for effective antiarrhythmic and antiepileptic treatment. Intravenous injection of 250 mg phenytoin followed by infusion of 750 mg phenytoin in a mean dosage of 1.7 mg/kg x h in nine patients with epilepsy produced plasma concentrations of 10.2 resp. 15.1 mug/ml after 4 resp. 8h. An oral maintenance therapy of 5-6 mg/kg is suggested. Therapeutic plasma concentrations were rapidly reached with this regimen.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 846182     DOI: 10.1007/BF01487714

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  33 in total

1.  Effect of ethanol intake on phenytoin metabolism in volunteers.

Authors:  D Schmidt
Journal:  Experientia       Date:  1975-11-15

2.  [Infusion of phenytoin concentrate in a child (author's transl)].

Authors:  W Oelkers; H Schäfer; H Reith
Journal:  Dtsch Med Wochenschr       Date:  1975-05-02       Impact factor: 0.628

Review 3.  Individualization of anticonvulsant therapy.

Authors:  A J Atkinson
Journal:  Med Clin North Am       Date:  1974-09       Impact factor: 5.456

4.  Comparison of spectrophotometric and gas-liquid chromatographic measurements of serum diphenylhydantoin concentrations in epileptic out-patients.

Authors:  D Janz; D Schmidt
Journal:  J Neurol       Date:  1974-06-27       Impact factor: 4.849

Review 5.  Biochemical and genetic factors regulating dilantin metabolism in man.

Authors:  H Kutt
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

6.  [(Author's transl) Indications for phenytoin in cardiac arrhythmias].

Authors:  H W Hansen; B Marquort; W Pelz
Journal:  Dtsch Med Wochenschr       Date:  1974-03-29       Impact factor: 0.628

7.  Intramuscular diphenylhydantoin.

Authors:  J R Cote
Journal:  Ann Intern Med       Date:  1973-06       Impact factor: 25.391

8.  Blood levels of drug at the equilibrium state after multiple dosing.

Authors:  J G Wagner; J I Northam; C D Alway; O S Carpenter
Journal:  Nature       Date:  1965-09-18       Impact factor: 49.962

9.  Rate of elimination of tracer doses of phenytoin at different steady-state serum phenytoin concentrations in epileptic patients.

Authors:  G W Houghton; A Richens
Journal:  Br J Clin Pharmacol       Date:  1974-04       Impact factor: 4.335

10.  [The significance of cumulation and elimination for the determination of Phenytoin (diphenylhydantoin)].

Authors:  H Remmer; J Hirschmann; I Greiner
Journal:  Dtsch Med Wochenschr       Date:  1969-06-13       Impact factor: 0.628

View more
  2 in total

1.  Serum anticonvulsant concentrations and the risk of drug induced skin eruptions.

Authors:  D Chadwick; M D Shaw; P Foy; M D Rawlins; D M Turnbull
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-06       Impact factor: 10.154

Review 2.  The new anticonvulsant drugs. Implications for avoidance of adverse effects.

Authors:  D Schmidt; G Krämer
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.